CSR at Galapagos – Summary
CSR at Galapagos – Summary
CSR report
Material Aspect 1: Improving people’s lives
SDG
Areas of engagement
- We are pioneering for patients and our mission is to discover and develop innovative medicines that address high unmet medical needs
- Our science and innovation are based on our flexible target discovery platform
- We commit to an ambitious R&D goal of maintaining an active portfolio of 30 projects
- We are building a deep early-stage R&D pipeline
- We aim to extend our commercial reach with filgotinib in Europe
- We aim to bring our innovation to patients suffering from severe diseases
- We accelerate innovation through win-win partnerships
Material Aspect 2: Our employees are the strength behind Galapagos
SDG
Areas of engagement
- We strive for gender equality
- We aim to continue to develop an inclusive and diverse workforce
- We implemented an employee reward, recognition, and retention program
- We are involved with local communities and charities
- We promote a career in science by engaging in STEM initiatives
Material Aspect 3: Conducting business ethically and responsibly
SDG
Areas of engagement
- Animal welfare in drug development
- Our clinical trials ethics
- Access to our medicines
- Our code of business conduct and ethics
Material Aspect 4: We care about the environment, health and safety
SDG
Areas of engagement
- We strive for a minimal environmental impact
- We are compliant with our sector rules and regulations
- We ensured our "license to work" during the COVID-19 pandemic
- We strengthened our company-wide EHS structure and management system